Clinical Trial: A Long-term Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis

U.S., Dec. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07285304) titled 'A Long-term Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis' on Nov. 24.

Brief Summary: A clinical study to evaluate the long-term safety and efficacy of TS-172 in hyperphosphatemia patients on hemodialysis.

Study Start Date: Dec. 01

Study Type: INTERVENTIONAL

Condition: Hyperphosphatemia Patients on Hemodialysis

Intervention: DRUG: TS-172

oral administration of TS-172 20~60 mg/day

Recruitment Status: RECRUITING

Sponsor: Taisho Pharmaceutical Co., Ltd.

Disclaimer: Curated by HT Syndication....